# ADREVIEW
> **NDA022290** · New Drug Application · Sponsor: GE HEALTHCARE · Approved 2008-09-19
## Drug
- **FDA Application Number:** NDA022290
- **Application type:** New Drug Application
- **Brand name:** ADREVIEW
- **Generic name:** IOBENGUANE I-123
- **Active ingredients:** IOBENGUANE SULFATE I-123
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** GE HEALTHCARE
- **Manufacturer:** Medi-Physics Inc.
- **First approval:** 2008-09-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022290)
---
*MORVS · CC0 1.0*